Eli Lilly and Merck’s blockbuster drug sales power earnings ⊕⊕
found
a story from Financial Times ✅ › Financial Times
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2025 › October › 30
Zepbound
8 months ago
Pharma groups boost financial outlooks as revenues from flagship medicines like Zepbound and Keytruda leap
Eli Lilly blows past estimates, hikes guidance as Zepbound and Mounjaro sales soar ○
found
a story from CNBC ⚠️ › World News
The results come as Eli Lilly works to maintain its edge over Novo Nordisk in the booming market for a class of obesity and diabetes drugs called GLP-1s.
page 1 of 1